Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology

T. Abo, J. C. Roder, W. Abo, M. D. Cooper, Charles M. Balch

Research output: Contribution to journalArticle

Abstract

Children with the Chediak-Higahi (CH) syndrome are known to have abnormalities of natural killer (NK) cell function. We used the HNK-1 monoclonal antibody that reacts specifically with human NK and K cells to distinguish whether this abnormality was due either to a numerical deficiency of NK cells or a defect in their ability to function. In eight CH patients, a significant proportion of their blood mononuclear cells (10-19%) expressed the HNK-1 differentiation antigen. The level of NK cells in the five children with CH syndrome was higher than for age-matched normal controls (15.8% vs. 5.8% P <0.001). When HNK-1+ cells were isolated with a fluorescence-activated cell sorter, the NK cells from CH patients were a homogeneous population of lymphocytes with a single large granule rather than the multiple small granules seen in NK cells from normal individuals. The purified HNK-1+ cells from the CH patients had minimal NK or K cell function. The CH syndrome thus includes a functionally defective population of NK cells that retain the capability of expressing the HNK-1 differentiation antigen.

Original languageEnglish (US)
Pages (from-to)193-197
Number of pages5
JournalJournal of Clinical Investigation
Volume70
Issue number1
StatePublished - 1982
Externally publishedYes

Fingerprint

Natural Killer Cells
CD57 Antigens
Differentiation Antigens
Population
Blood Cells
Fluorescence
Monoclonal Antibodies
Lymphocytes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology. / Abo, T.; Roder, J. C.; Abo, W.; Cooper, M. D.; Balch, Charles M.

In: Journal of Clinical Investigation, Vol. 70, No. 1, 1982, p. 193-197.

Research output: Contribution to journalArticle

@article{11b846a7c56b45fbad689618ad61e68c,
title = "Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology",
abstract = "Children with the Chediak-Higahi (CH) syndrome are known to have abnormalities of natural killer (NK) cell function. We used the HNK-1 monoclonal antibody that reacts specifically with human NK and K cells to distinguish whether this abnormality was due either to a numerical deficiency of NK cells or a defect in their ability to function. In eight CH patients, a significant proportion of their blood mononuclear cells (10-19{\%}) expressed the HNK-1 differentiation antigen. The level of NK cells in the five children with CH syndrome was higher than for age-matched normal controls (15.8{\%} vs. 5.8{\%} P <0.001). When HNK-1+ cells were isolated with a fluorescence-activated cell sorter, the NK cells from CH patients were a homogeneous population of lymphocytes with a single large granule rather than the multiple small granules seen in NK cells from normal individuals. The purified HNK-1+ cells from the CH patients had minimal NK or K cell function. The CH syndrome thus includes a functionally defective population of NK cells that retain the capability of expressing the HNK-1 differentiation antigen.",
author = "T. Abo and Roder, {J. C.} and W. Abo and Cooper, {M. D.} and Balch, {Charles M.}",
year = "1982",
language = "English (US)",
volume = "70",
pages = "193--197",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology

AU - Abo, T.

AU - Roder, J. C.

AU - Abo, W.

AU - Cooper, M. D.

AU - Balch, Charles M.

PY - 1982

Y1 - 1982

N2 - Children with the Chediak-Higahi (CH) syndrome are known to have abnormalities of natural killer (NK) cell function. We used the HNK-1 monoclonal antibody that reacts specifically with human NK and K cells to distinguish whether this abnormality was due either to a numerical deficiency of NK cells or a defect in their ability to function. In eight CH patients, a significant proportion of their blood mononuclear cells (10-19%) expressed the HNK-1 differentiation antigen. The level of NK cells in the five children with CH syndrome was higher than for age-matched normal controls (15.8% vs. 5.8% P <0.001). When HNK-1+ cells were isolated with a fluorescence-activated cell sorter, the NK cells from CH patients were a homogeneous population of lymphocytes with a single large granule rather than the multiple small granules seen in NK cells from normal individuals. The purified HNK-1+ cells from the CH patients had minimal NK or K cell function. The CH syndrome thus includes a functionally defective population of NK cells that retain the capability of expressing the HNK-1 differentiation antigen.

AB - Children with the Chediak-Higahi (CH) syndrome are known to have abnormalities of natural killer (NK) cell function. We used the HNK-1 monoclonal antibody that reacts specifically with human NK and K cells to distinguish whether this abnormality was due either to a numerical deficiency of NK cells or a defect in their ability to function. In eight CH patients, a significant proportion of their blood mononuclear cells (10-19%) expressed the HNK-1 differentiation antigen. The level of NK cells in the five children with CH syndrome was higher than for age-matched normal controls (15.8% vs. 5.8% P <0.001). When HNK-1+ cells were isolated with a fluorescence-activated cell sorter, the NK cells from CH patients were a homogeneous population of lymphocytes with a single large granule rather than the multiple small granules seen in NK cells from normal individuals. The purified HNK-1+ cells from the CH patients had minimal NK or K cell function. The CH syndrome thus includes a functionally defective population of NK cells that retain the capability of expressing the HNK-1 differentiation antigen.

UR - http://www.scopus.com/inward/record.url?scp=0019946730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019946730&partnerID=8YFLogxK

M3 - Article

C2 - 7085883

AN - SCOPUS:0019946730

VL - 70

SP - 193

EP - 197

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -